These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9057632

  • 21. CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
    Papadopoulos KP, Ayello J, Reiss RF, Troxel A, Kaufman E, Vahdat LT, Antman KH, Hesdorffer CS.
    J Hematother Stem Cell Res; 1999 Aug; 8(4):357-63. PubMed ID: 10634173
    [Abstract] [Full Text] [Related]

  • 22. Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group.
    Yeung AW, Pang YK, Tsang YC, Wong SW.
    Cancer; 1994 Apr 01; 73(7):1960-70. PubMed ID: 7511042
    [Abstract] [Full Text] [Related]

  • 23. Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood.
    Pettengell R, Woll PJ, Thatcher N, Dexter TM, Testa NG.
    J Clin Oncol; 1995 Jan 01; 13(1):148-56. PubMed ID: 7528271
    [Abstract] [Full Text] [Related]

  • 24. Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
    Kritz A, Crown JP, Motzer RJ, Reich LM, Heller G, Moore MP, Hamilton N, Yao TJ, Heelan RT, Schneider JG.
    Cancer; 1993 Apr 15; 71(8):2515-21. PubMed ID: 8095854
    [Abstract] [Full Text] [Related]

  • 25. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J, Moraleda JM, Ortuño F, Lozano ML, Ayala F, Vallejo C, de Arriba F, Vicente V.
    Bone Marrow Transplant; 2000 Feb 15; 25(3):231-5. PubMed ID: 10673692
    [Abstract] [Full Text] [Related]

  • 26. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
    MacVittie TJ, Farese AM, Davis TA, Lind LB, McKearn JP.
    Exp Hematol; 1999 Oct 15; 27(10):1557-68. PubMed ID: 10517498
    [Abstract] [Full Text] [Related]

  • 27. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J.
    Blood; 1993 Apr 01; 81(7):1709-19. PubMed ID: 7681699
    [Abstract] [Full Text] [Related]

  • 28. A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancer.
    Schwartzberg LS, Weaver CH, Birch R, Manner C, Tauer K, Beeker T, Morgan-Ihrig C, MacAneny B, Leff R, Smith R, Hainsworth J, Greco T, Schwerkoske J, Murphy MN, Buckner CD.
    J Hematother; 1998 Apr 01; 7(2):141-50. PubMed ID: 9597571
    [Abstract] [Full Text] [Related]

  • 29. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
    Knudsen LM, Gaarsdal E, Jensen L, Nielsen KJ, Nikolaisen K, Johnsen HE.
    J Hematother; 1996 Aug 01; 5(4):399-406. PubMed ID: 8877715
    [Abstract] [Full Text] [Related]

  • 30. Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
    Gajewski JL, Rondon G, Donato ML, Anderlini P, Korbling M, Ippoliti C, Benyunes M, Miller LL, LaTemple D, Jones D, Ashby M, Hellmann S, Durett A, Lauppe J, Geisler D, Khouri IF, Giralt SA, Andersson B, Ueno NT, Champlin R.
    Biol Blood Marrow Transplant; 2002 Aug 01; 8(10):550-6. PubMed ID: 12434950
    [Abstract] [Full Text] [Related]

  • 31. A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.
    Weaver CH, Zhen B, Schwartzberg L, Walker C, Upton S, Buckner CD.
    Am J Clin Oncol; 1998 Aug 01; 21(4):408-12. PubMed ID: 9708644
    [Abstract] [Full Text] [Related]

  • 32. Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients.
    Nowrousian MR, Waschke S, Bojko P, Welt A, Schuett P, Ebeling P, Flasshove M, Moritz T, Schuette J, Seeber S.
    Ann Oncol; 2003 Aug 01; 14 Suppl 1():i29-36. PubMed ID: 12736228
    [Abstract] [Full Text] [Related]

  • 33. Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma.
    Raina V, Sharma A, Kumar R, Bhargava M.
    Cancer; 1996 Mar 15; 77(6):1073-8. PubMed ID: 8635126
    [Abstract] [Full Text] [Related]

  • 34. Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxel.
    Fleming DR, Goldsmith J, Goldsmith GH, Stevens DA, Herzig RH.
    J Hematother Stem Cell Res; 2000 Dec 15; 9(6):855-60. PubMed ID: 11177597
    [Abstract] [Full Text] [Related]

  • 35. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
    Lefrere F, Makke J, Fermand J, Marolleau J, Dal Cortivo L, Alberti C, Mouton V, Benbunan M, Miclea J.
    Bone Marrow Transplant; 1999 Sep 15; 24(5):463-6. PubMed ID: 10482928
    [Abstract] [Full Text] [Related]

  • 36. Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.
    Dercksen MW, Gerritsen WR, Rodenhuis S, Dirkson MK, Slaper-Cortenbach IC, Schaasberg WP, Pinedo HM, von dem Borne AE, van der Schoot CE.
    Blood; 1995 Jun 01; 85(11):3313-9. PubMed ID: 7538823
    [Abstract] [Full Text] [Related]

  • 37. Peripheral blood stem cell mobilization with chemotherapy and granulocyte-colony stimulating factor in patients with hematological malignancies.
    Watanabe S, Mukaiyama T, Ogawa Y, Kawada H, Ichikawa Y.
    Tokai J Exp Clin Med; 1994 Dec 01; 19(3-6):143-55. PubMed ID: 7570686
    [Abstract] [Full Text] [Related]

  • 38. Serum G-CSF levels in patients undergoing G-CSF/chemotherapy mobilized peripheral stem cell harvest and predictors of neutrophil and platelet recovery.
    Maharaj D, Gómez-Marín O, Lewis-Ximenez LL, Riley R, Albarracín C.
    Leukemia; 1995 Oct 01; 9 Suppl 1():S113-7. PubMed ID: 7475301
    [Abstract] [Full Text] [Related]

  • 39. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM, Rosti G, Visani G, Gherlinzoni F, Miggiano MC, Fortuna A, Zinzani P, Tura S.
    J Clin Oncol; 1996 Nov 01; 14(11):3018-25. PubMed ID: 8918500
    [Abstract] [Full Text] [Related]

  • 40. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
    Brugger W, Henschler R, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L.
    Blood; 1994 Sep 01; 84(5):1421-6. PubMed ID: 7520769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.